Abstract:Elaborate regulation of innate immunity is necessary for the host to effectively respond to invading pathogens. As an important component of antiviral immunity transcription factors, the stability and activity of interferon (IFN) regulatory factor 3 (IRF3) are tightly controlled via multiple post-translational modifications. Here, we identified a human ovarian tumor domain-containing deubiquitinase OTUD6B as a positive regulator of IRF3 that facilitates type I IFN innate antiviral immune signaling. Mechanically, we found that OTUD6B interacts with IRF3 and directly hydrolyzes both the lysine 11 (K11)- and the lysine 33 (K33)-linked polyubiquitin chain, but only K33-linked polyubiquitin at Lys315 of IRF3 is responsible for IRF3 proteasome degradation. Notably, OTUD6B enhanced cellular antiviral responses in vivo, as evidenced by mice that overexpressed human OTUD6B were more resistant to RNA virus infection and had reduced viral load and morbidity. These findings revealed a previously unknown role for OTUD6B in the regulation of innate antiviral immunity and may provide a potential target for enhancing host antiviral defense.IMPORTANCE Interferon (IFN) regulatory factor (IRF3) is one of the key factors for type I IFN transcription. To sophisticatedly regulate type I IFN antiviral immune response, IRF3 activity is closely controlled by a variety of post-translational modifications. However, the regulatory mechanisms are still not fully elucidated. In the present study, we found that human deubiquitinase OTUD6B positively regulates IRF3-mediated antiviral immune response. OTUD6B can stabilize the IRF3 protein level via hydrolyzing (Lys33)-linked polyubiquitin at Lys315. More importantly, mice with OTUD6B overexpression exhibited more resistance to RNA virus infection. Thus, unlike the previous report that zebrafish OTUD6B negatively regulates the antiviral response by suppressing K63-linked ubiquitination of IRF3 and IRF7, we demonstrate that human OTUD6B actually enhances type I IFN response and has the potential for antiviral therapy.

Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination

OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3

Destabilizing the autoinhibitory conformation of Zap70 induces up-regulation of inhibitory receptors and T cell unresponsiveness

K33-linked Polyubiquitination of Zap70 by Nrdp1 Controls CD8(+) T Cell Activation.

K33-Linked Polyubiquitination of T Cell Receptor-ζ Regulates Proteolysis-Independent T Cell Signaling

Cbl Promotes Ubiquitination of the T Cell Receptor Ζ Through an Adaptor Function of Zap-70

USP1-regulated Reciprocal Differentiation of Th17 Cells and Treg Cells by Deubiquitinating and Stabilizing TAZ.

The deubiquitinating enzyme OTUD7b protects dendritic cells from TNF-induced apoptosis by stabilizing the E3 ligase TRAF2

Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation

Ubiquitination Signals Critical to Regulatory T Cell Development and Function

The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming.

Deubiquitinase OTUD6A Regulates Innate Immune Response Via Targeting UBC13

OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity

Deubiquitinase OTUD6a Drives Cardiac Inflammation and Hypertrophy by Deubiquitination of STING.

Regulation of T Cell Function by the Ubiquitin-Specific Protease USP9X Via Modulating the Carma1-Bcl10-Malt1 Complex.

Negative Regulation of Zap70 by Lck Forms the Mechanistic Basis of Differential Expression in CD4 and CD8 T Cells

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

Human OTUD6B Positively Regulates Type I IFN Antiviral Innate Immune Responses by Deubiquitinating and Stabilizing IRF3.

OTUD1 Regulates Antifungal Innate Immunity Through Deubiquitination of CARD9.